Diabetes Is One Condition, but Never Just One Risk
For decades, the conversation on diabetes has centered largely on controlling blood sugar. While that remains fundamental, diabetes needs to be understood within a wider metabolic picture, where excess weight, hypertension, lipid abnormalities, cardiovascular risk and kidney health often intersect and compound one another.
The scale makes this shift particularly significant. In 2024, an estimated 89.8 million Indian adults were living with diabetes, and about 43% were estimated to be undiagnosed. Yet the challenge is not simply to identify more people with diabetes. It is to ensure that diagnosis becomes the starting point for care that recognizes and manages the full spectrum of risks that determine a patient’s long-term health.
The next phase of diabetes care in India is about looking beyond glucose, with a broader focus on overall health and risk – from managing individual interventions to building a connected ecosystem of care around the patient.
The Need for Comprehensive Diabetes Management
We cannot manage risks that cannot be detected.
With a significant proportion of people with diabetes estimated to remain undiagnosed, early detection is an important starting point- one that identifies accompanying risks and enables intervention before complications arise.
A stronger diabetes ecosystem therefore begins upstream, increasing awareness, screening, primary care, diagnostics and timely clinical intervention. What matters is not only identifying more patients but ensuring that every diagnosis leads to the next step.
Treatment is an important step, but good diabetes care goes beyond blood sugar to support overall health.
The ICMR-INDIAB study clearly illustrates this gap. In India, only 7.7% of people with diabetes were found to meet recommended targets for blood glucose, blood pressure and LDL cholesterol together. This gap matters because diabetes complications are shaped by the combined burden of these risks, not by glucose in isolation.
HbA1c will remain an essential marker of diabetes management; yet it needs to be considered alongside other clinical factors that influence cardiovascular, renal and metabolic health. Understanding these factors together can support earlier, more individualized interventions and lead to meaningful long-term outcomes.
Understanding the person, not just the condition, allows care to be more personal.
Every patient needs a different treatment. Decisions need to reflect age, duration of disease, weight, cardiovascular and kidney health, risk of hypoglycemia, affordability and the patients’ ability to sustain therapy.
The expanding therapeutic landscape provides clinicians greater scope to respond to these differences. Newer therapeutic classes, including SGLT2 inhibitors and GLP-1 receptor agonists, have widened the clinical conversation beyond just glucose lowering. The opportunity now is to use this choice more intelligently, selecting and adapting therapy according to the patient’s broader risk profile and stage of disease.
The most appropriate treatment delivers its full value when every patient can sustain it.
Diabetes management takes place in the everyday decisions patients make about medication, nutrition, physical activity, monitoring and follow-up. Complexity, affordability, treatment fatigue and limited understanding of long-term risk can weaken adherence over time.
This is where the ecosystem becomes critical. Physicians remain central, but the larger ecosystem has a significant role to play. Patients and families, healthcare professionals, diagnostics, nutrition and lifestyle support, patient education and appropriate digital interventions can all contribute to sustained care.
The need is to move from prescription to participation, enabling patients not merely to receive treatment, but remain active partners in their health.
The value of innovation is a factor of timely diagnosis, appropriate selection, affordability, continued access and the ability to sustain therapy.
Access is therefore a critical factor in this journey.
No single stakeholder can address a lifelong, multifactorial condition at India's scale. The real opportunity lies in connecting these capabilities around a common purpose: ensuring that the patient can move seamlessly from detection to assessment, appropriate treatment and sustained care.
This leads to the transformation of healthcare interventions into an ecosystem of care.
At India’s scale of diabetes, the opportunity is to go beyond managing the disease to changing its long-term trajectory, reducing the risk of cardiovascular, renal and other complications. That requires us to detect earlier, assess more comprehensively, personalize intervention, support patients for the long term and make effective care accessible at scale. Together, they can create a very different diabetes journey.
Behind every HbA1c reading, prescription, and statistic is someone who wants to remain healthy enough to work, care for a family, pursue ambitions and live without diabetes defining the boundaries of their life.
Our measure of progress, therefore, should be how many people we help live longer, healthier lives without being defined by it.
This Op-ed was first published in the ET Healthworld on November 16, 2026